CombiMatrix launches customizable array platform

Nov. 10, 2003 — CombiMatrix Corp. will commercially launch a fully customizable DNA microarray platform early next year, according to a company news release.


CombiMatrix, an operating group of Newport Beach, Calif.-based Acacia Research Corp., said its CustomArray platform allows users to change array content rapidly. That will allow pharmaceutical, biotechnology and diagnostic companies to more efficiently identify, assess and validate new drug candidates or biological markers for further development, the release said.


The company will provide samples to select customers later this year, and market the product in March.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.